Other
2030
Merck & Co. 2030 increased by 42.9% to $3.00B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 42.9%, from $2.10B to $3.00B. Over 5 years (FY 2020 to FY 2025), 2030 shows an upward trend with a 16.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ4 2025Feb 24, 2026
How to read this metric
Lower maturity amounts in distant years provide greater flexibility for future capital allocation.
Detailed definition
This represents the specific portion of long-term debt principal scheduled for repayment during the 2030 fiscal year. It...
Peer comparison
Long-dated maturities are common for companies with stable, long-term government contracts.
Metric ID:
other_long_term_debt_maturities_repayments_of_principal__a540ccHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $2.50B | $2.20B | $1.50B | $2.10B | $3.00B |
| QoQ Change | — | -12.0% | -31.8% | +40.0% | +42.9% |
| YoY Change | — | -12.0% | -31.8% | +40.0% | +42.9% |
Range$1.50B – $3.00B
CAGR+20.0%
Avg YoY Growth+9.8%
Median YoY Growth+14.0%
Current Streak2 quarters growth
2030 at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s 2030?
- Merck & Co. (MRK) reported 2030 of $3.00B in Q4 2025.
- How has Merck & Co.'s 2030 changed year-over-year?
- Merck & Co.'s 2030 increased by 42.9% year-over-year, from $2.10B to $3.00B.
- What is the long-term trend for Merck & Co.'s 2030?
- Over 5 years (2020 to 2025), Merck & Co.'s 2030 has grown at a 16.5% compound annual growth rate (CAGR), from $1.40B to $3.00B.
- What does 2030 mean?
- The amount of long-term debt principal that must be repaid in 2030.